Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024

HROW 10.31.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-14
Name of Upcoming Event:Conference Call
Full Press ReleaseSEC FilingsOur HROW Tweets

About Gravity Analytica

Recent News

  • 01.13.2025 - Amir Shojaei
  • 01.07.2025 - Harrow Appoints Amir H. Shojaei as Chief Scientific Officer
  • 12.04.2024 - Piper Sandler 36th Annual Healthcare Conference

Recent Filings

  • 01.21.2025 - 8-K Current report
  • 01.08.2025 - 3 Initial statement of beneficial ownership of securities
  • 01.08.2025 - 4 Statement of changes in beneficial ownership of securities
PDF Version

Company to Host Conference Call to Discuss Results at8:00 a.m. Eastern TimeonNovember 14, 2024

NASHVILLE, Tenn.--(BUSINESS WIRE)--Oct. 31, 2024--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the third quarter endedSeptember 30, 2024, onWednesday, November 13, 2024, after the market close. The Company will also post its third quarter Letter to Stockholders to the “Investors” section of its website,harrow.com. Harrow will host a conference call and live webcast at8:00 a.m. Eastern TimeonThursday, November 14, 2024, to discuss the results and provide a business update.

Conference Call Information

Participants can access the live conference call via webcast on the “Investors” page of Harrow’s website. To participate via telephone, please register in advance using thislink. Upon registration, all telephone participants will receive a confirmation email with detailed instructions, including a unique dial-in number and PIN, for accessing the call. A replay of the conference call and webcast will be archived on the Company’s website for one year.

About Harrow

Harrow, Inc.(Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visitharrow.com.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241031905317/en/

Jamie WebbDirector of Communications and Investor Relationsjwebb@harrowinc.com615-733-4737

Source:Harrow, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com